Delivery Order SPE2DR25D2101-SPE2DR26F46ZB
Award Date 1/2/26
Potential Completion Date 1/5/26
Potential Value $9.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,327.94 delivery order to AmerisourceBergen Drug Corp for Actemra ActPen 162 mg/0.9 mL auto-injector pens on December 18, 2025, with completion scheduled for December 19, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract specifies performance at...
- The Defense Logistics Agency awarded a $13,863.71 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Actemra (tocilizumab) Actpen 162 mg/0.9 mL auto-injector pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of November 18, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,720.54 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injector pens. This firm fixed-price delivery order, issued on January 2, 2026, with an ultimate completion date of January 5, 2026, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.88 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 ml auto-injectors. This firm fixed-price, non-set-aside contract was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Actemra (tocilizumab) is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $1,885.82 to AmerisourceBergen Drug Corp for ACTEMRA ACTPEN 162 mg/0.9 mL auto-injector pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 22, 2025. The award was issued on December 19, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ACTEMRA (tocilizumab) is a biologic immunosuppressant used to treat rheumatoid arthritis and...
- The Defense Logistics Agency awarded a delivery order valued at $12,326.27 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL auto-injectors. This firm fixed price, non-set-aside contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication used primarily to treat rheumatoid arthritis and other...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Actemra ActPen (162 mg/0.9 mL) auto-injectors. This firm fixed price delivery order carries a ceiling value of $3,066.26 and is scheduled for completion by August 19, 2025. The contract was competitively awarded without set-aside provisions, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements....
- The Defense Logistics Agency awarded a $49,520.75 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Actemra ActPen 162 mg/0.9 ml auto-injector pens. This firm fixed-price, non-set-aside contract is scheduled for completion by December 8, 2025, with performance to be fulfilled from the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Actemra Actpen 162 mg/0.9 ml auto-injector pens, with a ceiling value of $1,259.18. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The order is set for ultimate completion by November 21, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $24,820.36 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL auto-injector pens. This firm fixed price, non-set-aside contract was awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions,...